ASSESSMENT OF ACUTE PHASE PROTEINS AND PROTEIN ELECTROPHORESIS IN HEALTHY GIBBONS (HYLOBATIDAE) IN MANAGED SETTINGS

Acute phase proteins (APP) and protein electrophoresis (EPH) offer crucial insights into inflammation and overall health in various species. In this study, we validated serum amyloid A (SAA) and C-reactive protein (CRP) reagents for use with serum samples from gibbons (Hylobatidae, <i>n</i> = 50), spanning five species across four gibbon genera: eastern hoolock (<i>Hoolock leuconedys</i>), Javan (<i>Hylobates moloch</i>), pileated (<i>Hylobates pileatus</i>), siamang (<i>Symphalangus syndactylus</i>), and white-cheeked (<i>Nomascus leucogenys</i>). Preliminary reference intervals (<i>n</i> = 50) were calculated for SAA (1.8-48.1 mg/L), CRP (0.1-11.1 mg/L), and EPH via capillary zone electrophoresis, in healthy gibbons. Comparing clinically normal (<i>n</i> = 38) and abnormal (<i>n</i> = 12) individuals, significant differences were observed in the albumin/globulin ratio (<i>P</i> = 0.0003), prealbumin (<i>P</i> = 0.0345), and albumin (<i>P</i> = 0.0094), with abnormal individuals exhibiting statistically significantly higher γ-globulins (<i>P</i> = 0.0224), SAA (<i>P</i> = 0.0001), and CRP (<i>P</i> = 0.0003). Despite significant chromosomal rearrangements among different gibbon species, we found no statistically significant differences of SAA and CRP levels across species. However, some differences between species were observed in EPH fractions. This study presents the first report of the evaluation of APP and EPH in gibbons, underscoring the potential use of these biomarkers in gibbon health monitoring. Further research with larger sample sizes of both normal and abnormal gibbons is recommended to solidify the clinical utility of these biomarkers in these species.